Clinical effects observation of BiPAP combined with inhalation Terbutaline plus Ambroxol in the treatment of AECOPD patients with type Ⅱ respiratory failure

Wan-ning Tong,Yu-shu Cao,An-shan Zhuo,Jie Dong
DOI: https://doi.org/10.3969/j.issn.1671-3826.2012.06.051
2012-01-01
Abstract:Objective To evaluate the clinical effects of Bi-level positive airway pressure(BiPAP) combined with inhalation Terbutaline plus Ambroxol in the treatment of acute exacerbation chronic obstructive pulmonary disease(AECOPD) patients with type Ⅱ respiratory failure. Methods Eighty four AECOPD patients with type Ⅱ respiratory failure in our hospital from October 2008 to October 2011 were divided into group A(43 cases) and group B(41 cases) and clinically analyzed.The routine treatment including oxygen inhalation,eliminating phlegm,relieving asthma,anti-infection and BiPAP was given to patients in both groups,while inhalation Terbutaline plus Ambroxol was added to patients in group B.The blood gas analysis,HR and RR before and after treatment as well as days of hospitalization,intubation rate and mortality were observed. Results Blood gas analysis,HR and RR of the patients in two groups were significantly improved(P<0.01) and the improvement in group B was much superior to that of the patients in group A with obvious statistic difference(P<0.05);there was no significant difference between the two groups in the total effective rate(P>0.05),but the excellence rate of group B was higher and has statistical significance with that of group A(P<0.05);The duration in hospital was shorter in the group B than that in the group A(P<0.05). Conclusion BiPAP combined with inhalation Terbutaline plus Ambroxol is better than BiPAP treatment alone in the treatment of AECOPD patients with type Ⅱ respiratory failure.
What problem does this paper attempt to address?